Abstract

We present the findings of a six-year surveillance period (2005–2010) of human West Nile virus (WNV) infection in Tel Aviv district, Israel. Initial notifications of positively identified patients received from the Central Virology Laboratory were followed by epidemiological investigations of the local district health office. During 2005–2010, 104 patients, 79 with WNV neuroinvasive and 25 with WNV non-neuroinvasive disease were reported. The median age of the patients with a neuroinvasive disease was 74 years (range: 15 to 95 years) and 53 of such patients had encephalitis, 14 had acute flaccid paralysis, and 12 had meningitis. The case-fatality rate in these patients was 8%. The average annual incidence of neuroinvasive disease during 2005–2010 was 1.08 per 100,000 population. The incidence declined by 86% steadily between 2005 and 2009 (p for trend=0.005), but increased by more than six-fold in 2010. Elderly (≥65 years) men, comprising 25 patients of whom 24 were chronically-ill, had the highest incidence of WNV encephalitis <0.001). These findings are concordant with previous data, at the national level, published in Israel and the United States. Notably, the percentage of previously healthy patients, who developed a neuroinvasive disease was the highest (37%, p=0.001) in the surveillance period in 2010.

Highlights

  • West Nile virus (WNV) is a mosquito-borne arbovirus of the family Flaviviridae

  • A national surveillance system was established for humans and mosquitoes [5] and since 2001 WNV infection is notifiable in Israel

  • The system is based on initial notifications of probable or confirmed cases of WNV infection by the Central Virology Laboratory (CVL) and on the subsequent epidemiological investigations of these patients by the local district health offices

Read more

Summary

Introduction

West Nile virus (WNV) is a mosquito-borne arbovirus of the family Flaviviridae. Numerous avian species serve as the amplifying hosts. Human West Nile fever, caused by laboratory-confirmed WNV infection, was reported in Israel for the first time in the early 1950s, with several outbreaks in that decade, and an additional outbreak in 1980 [3]. The largest outbreak (439 serologically-confirmed cases with 29 deaths) of human WNV infection in Israel occurred in 2000, with a 73% rate of neuroinvasive disease in hospitalised patients [3,4]. Following this outbreak, a national surveillance system was established for humans and mosquitoes [5] and since 2001 WNV infection is notifiable in Israel. The system is based on initial notifications of probable or confirmed cases of WNV infection by the Central Virology Laboratory (CVL) and on the subsequent epidemiological investigations of these patients by the local district health offices

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.